1h Free Analyst Time
The pharmaceutical market in Denmark is forecasted to grow by USD 852.1 mn during 2023-2028, accelerating at a CAGR of 3.63% during the forecast period. The report on the pharmaceutical market in Denmark provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high investment in pharmaceutical industry, growing prevalence of chronic conditions in Denmark, and increasing geriatric population in Denmark.
The pharmaceutical market in Denmark is segmented as below:
By Class Type
- Musculoskeletal system
- Nervous system
- Respiratory system
- Others
By Distribution Channel
- Offline
- Online
By Type
- Prescription drugs
- OTC drugs
The report on the pharmaceutical market in Denmark covers the following areas:
- Pharmaceutical market in Denmark sizing
- Pharmaceutical market in Denmark forecast
- Pharmaceutical market in Denmark industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Class Type
7 Market Segmentation by Distribution Channel
8 Market Segmentation by Type
9 Customer Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the pharmaceutical market in Denmark: AbbVie Inc., ALK Abello AS, Amgen Inc., AstraZeneca PLC, Baxter International Inc., Bayer AG, Biogen Inc., DANCANN PHARMA A S, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Ferring BV, FUJIFILM Corp., Genmab AS, H Lundbeck AS, LEO Pharma AS, Novo Nordisk AS, ORIFARM GROUP A S, ResoTher Pharma, Takeda Pharmaceutical Co. Ltd., and Zealand Pharma A S.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is high demand for personalized medicines.'
According to the report, one of the major drivers for this market is the high investment in pharmaceutical industry.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- ALK Abello AS
- Amgen Inc.
- AstraZeneca PLC
- Baxter International Inc.
- Bayer AG
- Biogen Inc.
- DANCANN PHARMA A S
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Ferring BV
- FUJIFILM Corp.
- Genmab AS
- H Lundbeck AS
- LEO Pharma AS
- Novo Nordisk AS
- ORIFARM GROUP A S
- ResoTher Pharma
- Takeda Pharmaceutical Co. Ltd.
- Zealand Pharma A S
